- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
For starters, trouble for banks, drugs, energy and M&A.
Here is why CBS, Constellation Brands, Monsanto and Aetna will be winners in 2017.
York Capital Management founder Jamie Dinan explained how investors should play the Monsanto (MON), Bayer (BAYRY) deal.
The middle market in M&A may seem like opportunity knocking for bulge bracket bankers, except someone's building a wall.